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Abstract
Organophosphorus pesticides (OPs) were originally designed to affect the nervous system by inhibiting the enzyme
acetylcholinesterase, an important regulator of the neurotransmitter acetylcholine. Over the past years evidence is
mounting that these compounds affect many other processes. Little is known, however, about gene expression responses
against OPs in the nematode Caenorhabditis elegans. This is surprising because C. elegans is extensively used as a model
species in toxicity studies. To address this question we performed a microarray study in C. elegans which was exposed for
72 hrs to two widely used Ops, chlorpyrifos and diazinon, and a low dose mixture of these two compounds. Our analysis
revealed transcriptional responses related to detoxification, stress, innate immunity, and transport and metabolism of lipids
in all treatments. We found that for both compounds as well as in the mixture, these processes were regulated by different
gene transcripts. Our results illustrate intense, and unexpected crosstalk between gene pathways in response to chlorpyrifos
and diazinon in C. elegans.
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Introduction
Organophosphorus pesticides (OPs) are widely used to control
agricultural and household pests, and consequently these com-
pounds have been well studied for their impact on gene function
and physiology. Initially, OPs were designed to affect the nervous
system of pest organisms by inhibiting acetylcholinesterase
(AChE). This leads to a cholinergic hyper stimulation as a
common mode of action [1]. However, mounting evidence
suggests that this is not the only process that is being affected.
For instance, mice lacking AChE are hypersensitive to OPs toxic
effects, indicating that OPs inhibit targets other than AChE [2]. In
addition, neurotransmitter receptors, proteases and several other
enzymes interact with OPs to modify the consequences of AChE
inhibition [3]. Moreover, many OPs alter immune functions in
mammals by oxidative damage, metabolism modifications and
stress-related immunesupression [4].
Of the hundreds of OPs, chlorpyrifos (CPF) and diazinon (DZN)
are intensively used as insecticides and acaricides. CPF is the most
thoroughly studied OP and, like DZN and most OPs, is
desulfurated by cytochrome P450 enzymes (CYPs). CPF and
DZN share detoxification pathways and molecular targets as they
are structurally similar [5]. DZN, however, induces a different
inhibition ratio of AChE [6]. Some studies also investigated the
response of AChE to a combination of CPF and DZN [7,8]. Their
results suggest a greater inhibition of cholinesterase by CPF than
by DZN and a greater influence of CPF in the combination.
Likewise, kinetic models of humans and rats exposed to CPF and
DZN indicate an interaction between both compounds at the
enzymatic level. In particular, CPF and DZN seem to compete for
common CYPs [9].
Despite our knowledge about OPs responses in different
organisms, little is known about genome-wide gene expression
responses of OPs in the nematode Caenorhabditis elegans. This is
surprising because C. elegans has been well established as a model
for understanding human toxicology, especially for studying
neurotoxic compounds like OPs [10]. The effects of CPF on C.
elegans have also been investigated in contrast to other chemical
effects [11]. These studies showed that neurotoxic compounds
affect behaviour and movement in C. elegans. Additionally, gene
transcription changes by CPF were investigated by Roh & Choi
(2008) [12] who found that CPF regulates stress related genes. Still,
a comparative analysis of the genome-wide transcriptional
responses of C. elegans to DZN and CPF has not been conducted.
Here we measured genome wide gene transcription profiles of
C. elegans exposed to CPF and DZN and to a low dose mixture
(LDM) of both compounds. Gene Ontology (GO) and domain
enrichment analysis illustrates the complexity with novel and
known pathways associated to OPs response.
Materials and Methods
C. elegans culturing
The Bristol N2 strain was cultured on standard nematode
growth medium (NGM) with E. coli OP50 as food source.
Nematodes were bleached (0.5 M NaOH, 1% hypochlorite) to
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collect eggs which were inoculated in 9 cm dishes for toxicity
experiments. After 72 hours, nematodes were collected in the L3-
L4 stage, frozen in liquid nitrogen and kept at 280C until the
RNA extraction procedure.
Toxicant exposures
We analyzed gene expression in response to the toxicants at
concentrations below the EC50 values for different fitness traits as
reproduction (CPF: EC50= 3.5 mg/L [13] DZN: EC50 = 30 mg/
L [14]) or growth (CPF: EC50 = 14 mg/L [15]), Nematodes were
exposed to 0.5 mg/L of CPF (CyrenH/NufosH, Cheminova A/S
[Lemvig, Denmark]) and 1 mg/l of DZN (Supelco [Bellefonte,
Pennsylvania 16823, USA]). The low dose mixture (LDM) of the
two OPs contained the sum of both single concentrations (DZN
[1 mg/l] and CPF [0.5 mg/l]).
The experiment started with eggs placed on NGM dishes with
the OP-treatments and E. coli OP50 as food source. After
72 hours, worms from 4 petri dishes were collected as one sample.
A total of 6 replicates per treatment were collected (24 petri
dishes), and immediately frozen in liquid nitrogen until RNA
extraction. All the OPs were dissolved in acetone and added to
10 ml of NGM poured in each 9 cm petri dish used for the
culture. Nematodes without treatments were grown simultaneous-
ly with the same concentrations of acetone in a control culture.
Microarray experiments
RNA from nematodes was extracted following the Trizol
method, and the RNeasy Micro kit (Qiagen, Valencia, CA, USA)
was used to clean up the samples. Labeled cDNA was produced
with the kit Array 900 HS from Genisphere and Superscript II
from Invitrogen. The 60-mers arrays were purchased from
Washington University (http://genomeold.wustl.edu) and they
were hybridized following the Genisphere Array 900 HS protocol
with modifications. Extracts from CPF, DZN and the CPF/DZN
combination exposures were hybridized with the control samples
in each array. Six independent biological replicates were used per
treatment to produce six replicate microarrays per experiment in a
dye-swap design.
Microarray Analysis
A Perking & Elmer scanner was used to extract the raw
intensities from the microarrays. Normalization within arrays and
normalization between arrays of raw intensities was done using
loess method [16] and aquantile method [17], respectively. Both
methods are included in the Limma package [18] from R software
(www.r-project.org/). The Rank Product package [19] was used to
identify the differentially expressed genes between controls and
treatment in each experiment. Briefly, genes were ranked based on
up- or downregulation by the treatment in each experiment.
Then, for each gene a combined probability was calculated as a
rank product (RP). The RP values were used to rank the genes
based on how likely it was to observe them by chance at that
particular position on the list of differentially expressed genes. The
RP can be interpreted as a p-value. To determine significance
levels, the RP method uses a permutation-based estimation
procedure to transform the p-value into an e-value that addresses
the multiple testing problem derived from testing many genes
simultaneously. Genes with a percentage of false-positives (PFP)
,0.05 were considered differentially expressed between treat-
ments and control in each experiment.This method has the
advantage to identify genes with a response to the toxicants even
when the absolute effect of the response was low. Because we used
sub-lethal concentrations of the toxicants, methods that use
thresholds based on absolute fold change would not identify small
changes in gene expression. Moreover, RP has proved to be a
robust method for comparing microarray data from different
sources and experiments [20].
Gene Ontology (GO) data and functional domain data were
extracted from Wormbase release WB195 using the R package
BioMart [21]. GO terms and domains with less than 4 genes were
discarded. Over-represented groups of GO terms and functional
domains were identified using a hypergeometric test, with a
threshold of p-value,0.01. The hypergeometric test compared a
group of 396 GO terms, with 16,947 annotated genes, with the
GO terms associated with the significantly regulated genes in each
treatment (551,245 and 233 for CPF, DZN and the LDM). For
functional domains analysis, 1003 InterPro and Pfam domain
terms were used, with 8682 annotated genes.
The same hypergeometric test was used to determine significant
regulation of the different pathways analyzed. The lists of
regulated genes, in this case, were extracted from the original
publications. Groups sizes were 541 genes for the daf-16 pathway,
255 for the etl-2 pathway, 305 for the mdt-5 pathway, 320 for the
dbl-1 pathway, 143 for the pmk-1 pathway, and 290 genes for Cd
responsive genes. Annotated genes were all the unique genes on
the microarray, 18893.
Microarray data have been deposited in Gene Expression
Omnibus (www.ncbi.nlm.nih.gov/geo/), accession number
GSE16719.
Results and Discussion
Effects of CPF and DZN on transcript levels in C. elegans
We analyzed global gene transcription profiles of C. elegans
treated with CPF or DZN. These profiles were used to reveal
transcriptional responses of each OP. Compared to control worms,
551 and 245 genes were significantly regulated in CPF and DZN
treated worms, respectively. Of these genes, 126 were regulated by
either compound (Figure 1 and Table S1).
To gain insight into the biological processes associated with the
regulated genes, we determined which GO annotation terms were
over-represented. In both treatments, significantly enriched GO
terms (p,0.01, hypergeometric test) were related with detoxifica-
tion (monooxygenase activity), metabolic process, and transport of
lipids (Figure 2, Table 1 and Table S2). To add meaningful
information to the results from the GO term enrichment we
Figure 1. Transcriptional response to CPF, DZN and combina-
tion. Venn diagram showing significantly regulated genes by CPF (cyan
circle), DZN (orange circle), a combination of both (CPF + DZN, blue
circle) and their overlap.
doi:10.1371/journal.pone.0012145.g001
OPs Profiling in C. elegans
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extended our investigation by using a similar analysis with protein
domains associated to the regulated genes as categories (Figure 3
and Table S2). The significantly overrepresented groups (p,0.01,
hypergeometric test) also included domains related to detoxifica-
tion, stress-response, and transport of fatty acids. In addition, we
also found significantly enriched domains associated with other
metabolic pathways and immune response.
Detoxification of CPF and DZN
Enzymes and functional domains associated with detoxification
in C. elegans are mainly cytochrome P450 (CYP) and short-chain
dehydrogenase (SDR) in phase I of the xenobiotic metabolism,
and UDP-glucuronosil/transferase (UGT) and glutathione S
transferase (GST) in phase II [22]. Their implication in the
detoxification of CPF and DZN has been well characterized in
Figure 2. Differentially expressed genes within enriched GO terms in CPF, DZN and combination. Percentage of genes within each GO
terms significantly regulated in each treatment: CPF (cyan circle), DZN (orange circle) and a combination of both (blue circle). Only significantly
enriched GO terms for all the treatments are shown (p-value,0.01 using hypergeometric test). Full list of GO terms can be found in Table S2.
doi:10.1371/journal.pone.0012145.g002
Table 1. Major Gene Ontology (GO) terms represented in the different treatments.







catalytic activity GO:0003824 22 13 12 2
monooxygenase activity GO:0004497 13 13 12 6
lipid transporter activity GO:0005319 5 6 6 5
binding GO:0005488 32 15 19 4
iron ion binding GO:0005506 18 13 12 6
lipid transport GO:0006869 6 6 7 5
metabolic process GO:0008152 36 23 26 8
Determination of adult life span GO:0008340 17 10 5 3
electron carrier activity GO:0009055 19 16 14 6
oxidoreductase activity GO:0016491 17 7 8 1
transferase activity, transferring hexosyl groups GO:0016758 13 9 10 6
Heme binding GO:0020037 17 13 12 6
A summary of common significant (p-value,0.01, hypergeometric test) GO terms in each treatments is shown. The final column show the number of common genes
within a GO term in all the three treatments. Only GO terms significant in all the three treatments are shown. A complete list with all the GO terms and its correspondent
p-values can be found in Table S1.
doi:10.1371/journal.pone.0012145.t001
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different organisms [7,23]. In our experiment, 19 genes that code
for domains related to phase I responded to the CPF treatment,
whereas 14 genes with these domains responded to the DZN
treatment. Of those genes, 10 were shared between CPF and DZN
treatment, of which nine were CYPs. Five of those shared CYPs
belong to the cyp-35 subfamily, which has previously been
identified as strongly inducible by a range of xenobiotics in C.
elegans [24]. In addition, only one gene (F25D1.5) coding for an
SDR domain was regulated in both treatments.
Also genes coding for proteins with domains involved in phase
II of detoxification were affected by CPF (21) and DZN (14). From
those genes, 8 were affected by both treatments. One of these
common genes was cdr-1 (F35E8.1), a member of the cadmium
responsive genes family. Two other genes from this family were
affected only by CPF, cdr-4 (K01D12.11) and cdr-6 (K01D12.12),
and cdr-5 (K01D12.14) only by DZN. Whereas cadmium modifies
the expression levels of cdr-4 and cdr-1, the level of expression of
cdr-5 and cdr-6 are impervious to this metal’s presence [25].
Moreover, other stressors are capable of modulating cdr-4
expression, but until now, cdr-1 transcription has only been
induced by cadmium.
Role of the daf-16 pathway in response to OPs
Another gene involved in phase II of detoxification and shared
between treatments was gst-10 (Y45G12C.2). This gene acts
downstream of daf-16 (R13H8.1), a FOXO class transcription
factor involved in the insulin-like growth factor signalling in C.
elegans [26]. Detoxification genes are known to constitute a big
group among the identified up-regulated genes by daf-16 [26,27].
Other genes acting downstream daf-16 have also been associated
with toxic stress response. We found from those groups
metallothioneins (mtl) and vitellogenins (vit) to be affected by
CPF or DZN. DZN decreased the transcript levels of mtl-2
(T08G5.10), while CPF did not regulate any of the two mtl genes
present in C. elegans. Furthermore, vitellogenin genes, lipid-
binding proteins involved in lipid mobilization, were down-
regulated in both treatments. CPF modified the expression of 5
out of 6 members of the vit gene family (vit-1 to vit-3, vit-5, and
vit-6) while DZN regulated all 6 vit genes. Furthermore, both OPs
regulated collagen genes (34 by CPF, 16 by DZN) and major
sperm proteins type genes (33 by CPF, 3 by DZN) acting
downstream of daf-16. Many of these, have been associated with
stress responses, although their specific connection to these
responses remains unresolved [28,29]. The overlap in genes
affected by CPF and/or DZN and the daf-16 pathway suggest that
this pathway is a primary response pathway following exposure to
OPs.
OPs affect innate immunity genes
The insulin-like signalling pathway regulated by daf-16 is known
to induce the immune response as part of a general stress response
[30]. On the other hand, Lewis et al. (2009) [31] showed that OPs
regulate daf-16 in C. elegans as a key modulator of physiological
responses other than stress, including innate immune response.
Therefore, it is not surprising to find that lys-7 (C02A12.4), a gene
coding for a well defined antimicrobial lysozyme, was regulated by
Figure 3. Differentially expressed genes within enriched domains in CPF, DZN and combination. Major functional groups represented in
all the treatments: CPF (cyan circle), DZN (orange circle) and a combination of both (blue circle). The number of genes that show a functional domain
are shown in each case, indicating the common regulated genes. Only functional domains common and significant (p-value,0.01, hypergeometric
test) within the three treatments are shown. Functional domain categories were extracted from defined proteins domains in Wormbase release 190
using BioMart. Domains description: IPR001128=Cytochrome P450; IPR001747= Lipid transport protein, N-terminal; IPR001846 = von Willebrand
factor, type D; IPR002213=UDP-glucuronosyl/UDP-glucosyltransferase; IPR003366=CUB-like region.
doi:10.1371/journal.pone.0012145.g003
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both toxicants. This gene is presumed to promote resistance to
infection [32]. Interestingly, while lys-7 is up-regulated under both
OP treatments and suggests an immune response, spp-1 (T07C4.4)
was down-regulated by CPF, but not by DZN. This saposin is also
a well known pathogen responsive gene. However, suppression of
spp-1 during Pseudomonas aeruginosa infection seems to be under
regulation of a different pathway than daf-16 [33]. Therefore,
other gene pathways may participate in parallel to daf-16 insulin-
like pathway to promote stress and infection responses in C.
elegans as a result of OPs exposure.
To further investigate an innate immunity response to OPs, we
compared the regulated genes in our experiments with genes
associated with immune response and stress in C. elegans. An
indication that different genes are involved in stress and infection
response was found by Shapira, et al. 2006 [34]. The authors
compared genes regulated in response to P. aeruginosa with those
affected by cadmium. They reported several overlapping genes
among these two responses, but they concluded that a reaction to
infection is largely distinct from stress response. Based on this, we
considered that an innate immune reaction signature may be
distinguishable from OP stress response in C. elegans. Subse-
quently, we also compared our set of genes with the same set of
cadmium responsive genes and pathogens responsive genes
Shapira et al. used (Table 2). We found more genes overlapping
between the OPs affected genes and the cadmium responsive
genes. The similarities between genes modulated by OPs and by
cadmium suggest the implication of a common response
mechanism of gene expression responses to toxic compounds.
Nevertheless, the larger number of genes affected by OPs as well as
P. aeruginosa infection supports the idea of an innate immune
response to OPs. For example, a CUB-like domain (also known as
DUF141) containing gene (F55G11.2) is induced during infection
but repressed under cadmium exposure. This gene was up-
regulated in both OP treatments. Another gene (F08G5.6) up-
regulated in all OP treatments is strongly induced by infection but
not by cadmium.
The same study from Shapira and colleagues identified ELT-2,
a GATA transcription factor, as key regulator for transcriptional
responses to infection. ELT-2 together with SKN-1, also a
transcription factor, have been proposed as complementary
regulators of spp-1 during infection [33]. Since spp-1 is also
regulated by the daf-16 pathway, genes acting downstream of elt-2
and skn-1 may act in parallel to induce a combined stress-immune
response to CPF and DZN (Figure 4). In that sense, SKN-1 is
known to mediate an expression response of genes involved in
phase II of detoxification. To induce these genes, SKN-1 is
phosphorylated through the PMK-1 p38 mitogen-activated
protein kinase pathway (p38 MAPK) [35]. Genes regulated by
pmk-1 are essential for immune and stress responses in C. elegans.
These genes code for antimicrobials proteins with CUB-like
domains, C-type lectins domains, ShK domains, and DUF274
domains [36]. Our domain enrichment analysis showed that OPs
regulated genes involved in phase II of detoxification. It also
showed an overrepresentation of domains associated to innate
immune response through the pmk-1/skn-1 pathway (Table S2).
Therefore, we compared our data sets with the genes downstream
pmk-1 identified by Troemel, et al. (2006) [36] (Table 2). We
found significant overlapping between genes belonging to this
pathway and the genes that were regulated in each treatment (13
genes, p-value,0.01) for CPF response, but not for DZN (5 genes,
p-value = 0.012). This strengthens the implication of this pathway
in response to CPF and indicates differences in immunomodula-
tion between CPF and DZN. Those differences have been already
reported in in vitro studies with human cells, where CPF showed a
stronger effect in cell viability and some immune parameters [37].
Altogether, CPF and DZN modified innate immunity related
genes in C. elegans in a different manner and as a part of complex
stress response.
Transcriptional effects of a the low dose mixture (LDM)
In the LDM, 233 genes were significantly regulated (Table S1),
of which 64 were affected by all, the combination and the both
single compound treatments (Figure 1). More genes (89) were
affected by the LDM only. The GO terms enrichment analysis
(Figure 2, Table 1 and Table S2) showed a significant modulation
of detoxification pathways, stress response, and transport and
metabolism of lipids, which is highly similar to the single
compound treatments. Moreover, the domain enrichment analysis
identified differentially expressed genes that code for CYP, SDR,
GST, UDP, C-type lectin, and CUB-like domains (Figure 3 and
Table S2).
Regulation of CYPs genes is required for detoxification of OPs
in the single and combined treatments. Our findings showed that
the OP combination regulated 12 CYPs (IPR001128), 6 of which
were also affected by CPF and DZN in single treatments. On the
other hand, 2 CYPs were regulated only in the combined











DAF-16 541 47 1.679e-10 36 2.920e-16 29 3.242e-11 [26]
ELT-2 255 30 1.779e-10 18 1.723e-09 21 3.562e-12 [34]
MDT-15 305 57 1.346e-28 29 1.319e-17 29 8.589e-18 [41]
DBL-1/SMA-9 320 31 1.224e-08 15 7.045e-06 22 2.829e-11 [40]
PMK-1 143 13 0.00019 5 0.01267 5 0.01190 [36]
Cd 290 44 9.917e-19 44 8.403e-35 40 2.447e-30 [28]
Pathway/mechanism investigated were: genes downstream daf-16 (DAF-16), genes regulated by the GATA transcription factor ELT-2 (ELT-2), genes regulated by the
Mediator subunit MDT-15 (MDT-15), genes downstream pmk-1 (PMK-1) and cadmium responsive genes (Cd). Number of genes associated with each pathway or
mechanism are shown. Overlapping genes are the number of genes belonging to a pathway that are regulated in each treatment. P-values were calculated using
hypergeometric test.
doi:10.1371/journal.pone.0012145.t002
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treatment. Differences in the regulated CYPs were expected,
because OPs seem to compete for binding sites of CYPs [9].
Moreover, in vitro analysis of CYPs metabolism of CPF and DZN
indicates that CPF inhibits the metabolism of DZN to IMHP (the
inactive pyrimidol derived from DZN), with no effect of DZN over
CPF metabolism. This inhibition seems to promote oxon synthesis
from DZN, and therefore, increases the total levels of oxon in the
organism after a treatment of more than one compound.
Moreover, the toxicity of OPs is determined by a balance between
bioactivation (production of oxon metabolite) and detoxification
(inactivation of OPs and its intermediate oxon) [5]. Therefore,
higher levels of DZN bioactivation, due to modification of this
balance, may be a reason for a greater-than-additive inhibition of
cholinesterase enzymes in mixtures of OPs [14,38]. At the
transcriptional level however, the number of CYPs regulated by
the combined treatment do not suggest a higher bioactivation.
Even though the combined treatment contained a higher
concentration of toxicants, a similar number of genes involved in
detoxification was regulated in the combined and the single
treatments. These results were not contradictory to the previous
studies, since a direct comparison between transcriptional and
physiological studies is difficult. Nevertheless, our results indicated
that dissimilar genes were involved in the regulation of
detoxification of the different OPs treatments and may explain
the differences between the LDM and the single treatments.
Other processes were modulated by all treatments besides
detoxification, these include: stress, fat metabolism and innate
immunity. The overlap between the analyzed pathways for the
single treatments and the regulated genes in the combinations was
significant (Table 2). Interestingly, as it is shown in the last column
of Table 1, the number of common genes associated to some of
these responses was low. For example, the modulation of stress and
innate immune genes was observed for the combined treatment.
Genes involved in response to infections were up-regulated such as
F55G11.2, F08G5.6 and genes with the CUB-like functional
domain (Figure 3 and Table S2). This again suggests an innate
immune response to OPs. Furthermore, the combined treatment
showed up-regulation of sma-9 (T05A10.1), a gene coding for a
transcriptional factor involved in body size regulation. This
transcriptional factor modulates a subset of genes in the TGF-b
signalling pathway which is associated with innate immunity,
aging and germ line regulation [39]. Of the identified genes in the
TGF-b signalling pathway [40], the combined treatment regulated
22 genes (Table 2). A closer look to the regulated genes by CPF
and DZN showed also the implication of this pathway in their
transcriptional responses. Once more, as in response to the pmk-1
pathway, CPF seems to regulate more genes implicated in innate
immunity, but the LDM did not show a stronger influence.
Likewise, genes downstream daf-16 and elt-2 were regulated in the
combined treatment.
Overall, as shown in Figure 4, the ingestion of CPF, DZN or a
low dose mixture of both induced many common responses like
stress and innate immunity pathways. The most regulated
pathways included genes modulated by MDT-15 (MDT-15),
Figure 4. A model for the transcriptional responses to CPF and DZN in C. elegans. Exposure to the toxicants CPF, DZN or a low dose mixture
(LDM) of both organophosphates modulates the expression of genes in common pathways. The most regulated pathways are shown with the thicker
arrows: genes regulated by MDT-15 (MDT-15), genes downstream daf-16 (DAF-16), and genes downstream elt-2 (ELT-2). For details, see Table 2.
Despite this common regulated pathways, the three treatments regulated different genes to induce common responses such a stress response,
response to ingested material or immune response. Here we show some regulated genes by chlorpyrifos (CPF), diazinon (DZN) and a low dose
mixture (LDM). With different colors are shown common regulated genes by chlorpyrifos and diazinon (CPF + DZN), by chlorpyrifos and low dose
mixture (CPF + LDM), and by diazinon and low dose mixture (DZN + LDM). An intense crosstalk between gene pathways in response to the toxicants
may be explain by the genes shared between pathways. For example, cdr-4 was regulated by CPF and LDM but not by DZN. Previous studies showed
that its expression is modulated by ELT-2 and DBL-1, two transcription factors implicated in responses to infection. Exposure to the toxicants
modulated the expression of many genes from those pathways that, acting in parallel, induced the detected responses. We analyzed regulated genes
within the Different genes within those common pathways regulate the common responses to all treatments.
doi:10.1371/journal.pone.0012145.g004
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genes downstream daf-16 (DAF-16), and genes downstream elt-2
(ELT-2). The three treatments regulated different genes within the
same pathways to induce the common responses. The analysis of
the regulated genes showed an intense crosstalk between gene
pathways involved in the toxicants response. This suggest that the
structural differences between CPF and DZN induced the
expression of different genes. These differences, however, are
not large enough to induce a specific different response to the
exposure of CPF or DZN.
Conclusion
We present an analysis and comparison of whole genome
transcription analysis of a model organism exposed to two
toxicants and a combination of both. Our results revealed that,
CPF and DZN induced dissimilar genes, even though they have a
similar chemical structure. The toxicants induced genes related to
detoxification, stress, innate immunity and response to ingested
material in single and combined treatment. The differences
between transcript responses in the combined treatment suggest
that the effect of a mix of low doses of CPF and DZN is not a
summed effect of the single components. But at the same time, the
similarities in the induced pathways (e.g.: daf-16, elt-2, snk-1/pmk-1,
sma-9) indicate the regulation of similar responses to them.
Supporting Information
Table S1 Differentially expressed genes in nematodes treated
with CPF (0.5 mg/l), DZN (1 mg/l), CPF (0.5 mg/l)+DZN
(1 mg/l). RankProduct (RP) was used to identify regulated genes
in each of the treatments. Each worksheet contains the output for
RP in one experiment. Sequence names for each regulated gene
are in gene.names column. Gene.index are the microarray index
for the original data. RP/sum are the rank product sum calculated
per each gene. FC:(class1/class2) are the expression fold change of
class 1 (treatment)/class 2 (control). pfp: estimated percentage of
false positive for each gene. P-value: estimated p-value for each
gene.
Found at: doi:10.1371/journal.pone.0012145.s001 (0.15 MB
XLS)
Table S2 Significantly enriched Gene Ontology (GO) terms and
functional domains. GO terms worksheets contain full GO
enriched analysis. Genes in GO database are the number of
genes belonging to each GO term. GO number are the GO term.
Regulated genes refer to number of significantly regulated genes in
each treatment that belong to a GO term. p-values were calculated
using hypergeometric test, values lower that 0.01 and more than
two genes in a category were considered significant. Functional
domains worksheets: Genes with the domain are the number of
genes that code for a specific functional domain. The number of
significantly regulated genes in each treatment that code for a
specific functional domain is listed in the regulated genes column.
The functional domains terms were extracted fromWormbase 195
using BioMart.
Found at: doi:10.1371/journal.pone.0012145.s002 (0.03 MB
XLS)
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